Skip to Content

'
Ritsuko R. Komaki, MD, FACR

Present Title & Affiliation

Primary Appointment

Adjunct Professor, School of Health Sciences, Houston, TX
Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
Gloria Lupton Tennison Distinguished Professorship in Lung Cancer, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
Program Director, Thoracic Radiation Oncology, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
Associate Medical Director, Thoracic Center, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1969 Hiroshima University School of Medicine, Hiroshima, Japan, MD, Medicine
1965 Hiroshima University, Hiroshima, Japan, BS

Postgraduate Training

1/1977-1/1978 Clinical Fellowship, The Medical College of Wisconsin, Milwaukee, WI
1/1973-1/1974 Clinical Fellowship, VA Hospital, Hematology/Oncology Department, Milwaukee, WI
1/1972-1/1973 Clinical Internship, St. Mary's Hospital, Milwaukee, WI
1/1971-1/1972 Extern, St. Mary's Hospital, Milwaukee, WI
1/1969-1/1970 Internal Medicine, Radiation Effects Research Foundation, Atomic Bomb Casualty Commission, Hiroshima, Japan

Board Certifications

1/1977 American Board of Radiology (Therapeutic Radiology)

Selected Publications

Peer-Reviewed Original Research Articles
1. Maru DM, Luthra R, Correa AM, White-Cross J, Anadasabapathy S, Krishnan S, Guha S, Komaki R, Swisher S, Anaji JA, Hofstetter WL, Rashid A. Frequent Loss of Heterozygosity of Chromosome 1q in Esophageal Adenocarcinoma: Loss of Chromosome 1q21.3 is Associated with Shorter Overall Survial. CANCER 115(7):1576-85, 4/2009.
2. Smith GL, Smith BD, Buchholz TA, Liao Z, Jeter M, Swisher SG, Hofstetter WL, Ajani JA, McAleer MF, Komaki R, Cox JD. Patterns of Care and Locoregional Treatment Outcomes in Older Esophageal Cancer Patients: The SEER-Medicare Cohort. Int J Radiat Oncol Biol Phys 74(2). e-Pub 3/14/2009. PMID: 19289262.
3. Javeri H, Xiao L, Rohren E, Komaki R, Hofstetter W, Lee JH, Maru D, Bhutani MS, Swisher SG, Wang X, Ajani JA. Influence of the baseline 18F-fluoro-2-deoxy-D-glucose positron emission tomography results on survival and pathologic response in patients with gastroesophageal cancer undergoing chemoradiation. Cancer 115(3):624-30, 2/1/2009. PMID: 19130466.
4. Rosenzweig KE, Movsas B, Bradley J, Gewanter RM, Gopal RS, Komaki RU, Kong FM, Lee HK, Feins RH, Langer CJ. ACR appropriateness criteria on nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intent. J Am Coll Radiol 6(2):85-95, 2/2009. PMID: 19179235.
5. Gayed IW, Liu HH, Wei X, Liao Z, Yusuf SW, Chang JY, Bassett R, Komaki R. Patterns of cardiac perfusion abnormalities after chemoradiotherapy in patients with lung cancer. Journal of Thoracic Oncology 4(2):179-84, 2/2009.
6. Britton KR, Starkschall G, Chang, JY, Bilton S, Ezhil M, John-Baptiste S, Kantor M, Cox JD, Komaki R, Mohan, R. Consequences of Anatomic Changes and Respiratory Motion on Radiation Dose Distributions in Conformal Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer. International Journal of Radiation Oncology Biology and Physics 73(1):94-102, 1/2009.
7. Zinner RG, Komaki R, Cox JD, Glisson BS, Pisters KM, Herbst RS, Kies M, Liao Z, Hong WK, Fossella FV. Dose Escalation of Gemcitabine Is Possible with Concurrent Chest Three-Dimensional Rather than Two-Dimensional Radiotherapy: A Phase I Trial in Patients with Stage III Non-Small-Cell Lung Cancer. International Journal of Radiation Oncology Biology and Physics 73(1):119-27, 1/2009. PMID: 18556142.
8. Ajani JA, Correa AM, Swisher SG, Komaki R, Wu TT, Lee JH, Walsh G, Vaporciyan A, Rice DC, Liao Z, Yao JC, Faust J, Ho L, Maru D, Phan AT, Hofstetter WL, Roth JA. Chemotherapy Combination Without a Platinum as Preoperative Therapy of Localized Carcinoma of the esophagus. Pending, 2009.
9. Sulman EP, Komaki R, Klopp AH, Cox JD, Chang JY. Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer. Radiat Oncol 4:5, 2009. PMCID: PMC2651897.
10. McDonald JM, Pelloski CE, Ledoux A, Sun M, Raso G, Komaki R, Wistuba II, Bekele BN, Aldape K. Elevated phospho-S6 expression is associated with metastasis in adenocarcinoma of the lung. Clin Cancer Res 14(23):7832-7, 12/1/2008. PMCID: PMC2614348.
11. Sarna L, Swann S, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Byhardt R, Wasserman T, Movsas B. Clinically Meaningful Differences in Patient-Reported Outcomes With Amifostine in Combination With Chemoradiation for Locally Advanced Non-Small-Cell Lung Cancer: An Analysis of RTOG 9801. International Journal of Radiation Oncology Biology and Physics 75(5):1378-84, 12/2008. PMID: 18501528.
12. Rice D, Swisher S, Pisters K, Fossella F, Herbst R, Hofstetter W, Kies M, Komaki R, Lippman S, Mehran R, Roth J, Stewart D, Vaporciyan A, Walsh G, Cox J. Comment on "Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)". Chest 134(6):1349; author reply 1350, 12/2008. PMID: 19059972.
13. McDonald JM, Pelloski CE, Ledoux A, Sun M, Raso G, Komaki R, Wistuba II, Aldape K. Elevated phospho-S6 expression predicts metastasis in early stage adenocarcinoma of the lung. Clinical Cancer Research 14(25):7832-7, 12/2008.
14. Cen P, Correa AM, Le JH, Maru D, Anandasabapathy S, Liao Z, Hofstetter WL, Swisher SG, Komaki R, Ross WA, Vaporciyan A, Ajani JA. Adenocarcinoma of the lower esophagus with Barrett's esophagus or without Barrett's esophagus: differences in patients' survival after preoperative chemoradiation. Dis Esophagus 22(1). e-Pub 11/19/2008. PMID: 19021684.
15. Jin H, Tucker SL, Liu HH, Wei X, Yom SS, Wang S, Komaki R, Chen Y, Martel MK, Mohan R, Cox JD, Liao Z. Dose-Volume Thresholds and Smoking Status for the Risk of Treatment-Related Pneumonitis in Inoperable Non-Small Cell Lung Cancer Treated with Definitive Radiotherapy. Radiother Oncol 91(3):427-32, 10/2008. e-Pub 10/18/2008. PMID: 18937989.
16. Zhang X, Zhao KL, Guerrero TM, McGuire SE, Yarmko B, Komaki R, Cox J, Hui Z, Li Y, Newhauser WD, Mohan R, Liao Z. Four-dimensional computed tomography-based treatment planning for intensity-modulated radiation therapy and proton therapy for distal esophagel cancer. Int J Radiat Oncol Bilo Phys 72(1):278-87, 9/2008. PMID: 18722278.
17. Wang H, Garden AS, Zhang L, Wei X, Ahamad A, Kuban DA, Komaki R, O'Daniel J, Zhang Y, Mohan R, Dong L. Performance evaluation of automatic anatomy segmentation algorithm on repeat or four-dimensional computed tomography images using deformable image registration method. Int J Radiat Oncol Biol Phys 72(1):210-9, 9/2008. PMID: 18722272.
18. Gayed IW, Chang J, Kim EE, Nunez R, Chaen B, Liu HH, Kobayashi K, Zhang Y, Liao Z, Gohar S, JEter M, Henderson L, Erwin W, Komaki R. Lung perfusion imaging can risk statify lung cancer patients for the development of pulmonary complications after chemoradiation. J Thorac Oncol 3(8):858-64, 8/2008. PMID: 18670303.
19. Maru DM, Khurana H, Rashid A, Correa MA, Anandasabapathy S, Krishnan S, Komaki R, Ajani JA, Swisher SG, Hofstetter WL. Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. Am J Surg Pathol 32(9):1404-11, 8/2008. PMID: 18670347.
20. Ajani JA, Winter K, Komaki R, Kelsen DP, Minsky BD Liao Z, Bradley J, Fromm M, Hornback D, Willett CF. Phase II Randomized Trail of Two Nonoperative Regimens of Induction Chemotherapy Followed by Chemoradiation in Patients with Localized Carcinoma of the Esophagus RTOG 0113. J Clin Oncol Epub ahead of print, 6/2008. PMID: 18574157.
21. Ogo E, Komaki R, Fujimoto K, Uchida M, Abe T, Nakamura K , Mitsumori M, Kenji Sekiguchi K , Kaneyasu Y, Hayabuchi N. Lung lesions beyond the radiation field after tangential breast radiation - Radiation induced bronchiolitis obliterans organizing pneumonia (BOOP) syndrome after breast conserving therap. International Journal of Radiation Oncology and Physics 71(1):123-31, 5/2008.
22. Tetzlaff ED, Correa A, Komaki R, Swisher SG, Maru D, Ross W, Ajani JA. The Significance of Thromboembolic Phenomena Occurring Before and During Chemoradiotherapy for Localized Carcinoma of the Esophagus and Gastroesophageal Junction. Dis Esophagus 21(7):575-81, 5/2008.
23. Hui Z, Zhang X, Starkschall G, Li Y, Mohan R, Komaki R, Cox J, Chang J. Effects of Interfractional Motion and Anatomic Changes on Proton Therapy Dose Distribution in Lung Cancer. Int. J. Radiation Oncology Biol. Phys 72(5):1385-1395, 3/2008.
24. Komaki R, et al. Non-Small cell lung cancer. J Natl Compr Canc Netw 6(3):228-69, 3/2008. PMID: 18377844.
25. Grosshans DR, Meyers CA, Allen PK, Davenport SD, Komaki R. Neurocognitive function in patients with small cell lung cancer : effect of prophylactic cranial irradiation. Cancer 112:589-595, 2/2008.
26. Ogo E, Komaki R, Fujimoto K, Uchida M, Abe T, Nakamura K, Mitsumori M, Sekiguchi K, Kaneyasu Y, Hayabuchi N. A survey of radiation-induced bronchiolitis obliterans organizing pneumonia syndrome after breast-conserving therapy in Japan. International Journal of Radiation Oncology Biology and Physics 71:123-131, 2008.
27. Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu C, Ajani JA, Phan A, Swisher SG, Mohan R, Cox JD, Komaki R. Association between systemic chemotherapy before chemoradiation and increased risk of treatment-related pneumonitis in esophageal cancer patients treated with definitive chemoradiotherapy. Journal of Thoracic Oncology 3(3):277-282, 2008.
28. Yaremko BP, Guerrero TM, McAleer MF, Bucci MK, Noyola-Martinez J, Nguyen LT, Balter PA, Guerra R, Komaki R, Liao Z. Determination of respiratory motion for distal esophagus cancer using four-dimensional computed tomography. International Journal of Radiation Oncology Biology and Physics 70:145-153, 2008.
29. Chang JY, Dong L, Liu H, Starkschall G, Balter P, Mohan R, Liao Z, Cox JD, Komaki R. Image-guided radiation therapy for non-small cell lung cancer. Journal of Thoracic Oncology 3(2):177-186, 2008.
30. Bruzzi JF, Komaki R, Walsh GL, Truong MT, Gladish GW, Munden RF, Erasmus JJ. Imaging of non-small cell lung cancer of the superior sulcus: part 1: anatomy, clinical manifestations, and management. Radiographics 28:551-560, 2008.
31. Bruzzi JF, Komaki R, Walsh GL, Truong MT, Gladish GW, Munden RF, Erasmus JJ. Imaging of non-small cell lung cancer of the superior sulcus: part 2: initial staging and assessment of resectability and therapeutic response. Radiographics 28:561-572, 2008.
32. Ettinger DS, Akerley W, Bepler G, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Feigenberg SJ, Figlin RA, Govindan R, Grannis FW Jr, Jahan T, Jahanzeb M, Kessinger A, Komaki R, Kris MG, Langer CJ, Le QT, Martins R, Otterson GA, Patel JD, Robert F, Sugarbaker DJ, Wood DE. Non-small cell lung cancer. Journal of the National Comprehensive Cancer Network 6:228-269, 2008.
33. Kased N, Erasmus JJ, Komaki R, Cox JD. Prognostic value of posttreatment [18F] fluorodeoxyglucose uptake of primary non-small cell lung carcinoma treated with radiation therapy with or without chemotherapy: a brief review. Journal of Thoracic Oncology 3:534-538, 2008.
34. Wei X,Liu H, Komaki R. Risk Factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive. International Journal of Radiation Oncology Biology and Physics 70(3):707-714, 2008.
35. Zhang X, Komaki R, Wang L, Fang B, Chang JY. Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus. Clinical Cancer Research 14:2813-2823, 2008.
36. Ezhil M, Starkschall G, Mohan R, Cox J, Komaki R. Validation of a model-based segmentation approach to propagating normal anatomic regions of interest through the 10 phases of respiration. International Journal of Radiation Oncology Biology and Physics 71:900-906, 2008.
37. Liu H, Komaki R. Preserving Functional Lung Using Perfusion Imaging and Intensity-Modulated Radiation Therapy for Advanced-Stage Non-Small-Cell Lung Cancer. International Journal of Radiation Oncology Biology and Physics 1(68(5)):1349-58, 8/2007. PMID: 17446001.
38. Fukui H, Komaki R, Okui M, Toyoshima K, Kuda K. The effects of odor on cortisol and testosterone in healty adults. Neuro Endocrinol Lett 28(4):433-7, 8/2007. PMID: 17693981.
39. Liu HH, Balter P, Tutt T, Choi B, Zhang J, Wang C, Chi M, Luo D, Pan T, Hunjan S, Starkschall G, Rosen I, Prado K, Liao Z, Chang J, Komaki R, Cox JD, Mohan R, Dong L. Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys 68:531-40, 6/2007.
40. Yaremko BP, Guerrero TM, Noyola-Martinez J, Guerra R, Lege DG, Nguyen LT, Balter PA, Cox JD, Komaki R. Reduction of Normal Lung Irradiation in Locally Advanced Non-small cell lung cancer patients using ventilation images for functional avoidance. Int J Radiat Oncol Bol Phys 68:562-71, 6/2007.
41. Mell LK, Malik R, Komaki R, Movsas B, Swann RS, Langer C, Antonadou D, Koukourakis M, Mundt AJ. Effect of amifostine on response rates in locally advanced non-small-cell lung cancer patients treated on randomized controlled trials: A meta-analysis. Int J Radiat Oncol Biol Phys 68:111-8, 5/2007. PMID: 17289291.
42. Yom SS, Liao Z, Liu HH, Tucker SL, Hu CS, Wei X, Wang X, Wang S, Mohan R, Cox JD, Komaki R. Initial Evaluation of Treatment-Related Pneumonitis in Advanced-Stage Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemotherapy and Intensity-Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys 68:94-102, 5/2007.
43. Podoloff DA, Advani RH, Allred C, Benson AB 3rd, Brown E, Burstein HJ, Carlson RW, Coleman RE, Czuczman MS, Delbeke D, Edge SB, Ettinger DS, Grannis FW Jr, Hillner BE, Hoffman JM, Kiel K, Komaki R, Larson SM, Mankoff DA, Rosenzweig KE, Skibber JM, Yahalom J, Yu JM, Zelenetz AD. NCCN Task Force Report: Positron Emission Tomography (PET)/Computed Tomography (CT) Scanning in Cancer. J Natl Compr Canc Netw Suppl 1:S1-S22, 5/2007.
44. Kang Y, Zhang X, Chang JY, Wang H, Wei X, Liao Z, Komaki R, Cox JD, Balter PA, Liu H, Zhu XR, Mohan R, Dong L. 4D Proton treatment planning strategy for mobile lung tumors. Int J Radiat Oncol Biol Phys 67:906-14, 3/2007. PMID: 17293240.
45. Itasaka S, Komaki R, Herbst RS, Shibuya K, Shintani T, Hunter NR, Onn A, Bucana CD, Milas L, Ang KK, O'Reilly M S. Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice. Int J Radiat Oncol Biol Phys 67:870-8, 3/2007. PMID: 17293237.
46. Guerrero T, Castillo R, Noyola-Martinez J, Torres M, Zhou X, Guerra R, Cody D, Komaki R, Travis E. Reduction of pulmonary compliance found with high-resolution computed tomography in irradiated mice. Int J Radiat Oncol Biol Phys 67:879-87, 3/2007. PMID: 17293238.
47. Gao XS, Qiao X, Wu F, Cao L, Meng X, Dong Z, Wang X, Gao G, Wu TT, Komaki R, Chang JY. Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma. Int J Radiat Oncol Biol Phys 67:389-96, 2/2007. PMID: 17236963.
48. Wu W, Onn A, Isobe T, Itasaka S, Langley RR, Shitani T, Shibuya K, Komaki R, Ryan AJ, Fidler IJ, Herbst RS, O'Reilly MS. Targeted therapy of orthotopic human lung cancer by combined vascular endothelial growth factor and epidermal growth factor receptor signaling blockade. Mol Cancer Ther 6:471-83, 2/2007. PMID: 17308046.
49. Britton KR, Starkschall G, Tucker SL, Pan T, Nelson C, Chang, JY, Cox JD, Mohan R, Komaki R. Assessment of gross tumor volume regression and motion changes during radiation therapy for non-small-cell lung cancer as measured by four-dimensional computed tomography. Int J Radiat Oncol Biol Phys 68:1036-1046, 2007.
50. Yendamuri S, Komaki R, Blackmon S, Correa A, Wynn B, Allen P, Hofstetter W, Rice,Roth J, Swisher S, Vapociyan AA, Walsh GL Mehran RJ. Comparison of Limited Surgery and Three-Dimetional Conformal Radiation in High-Risk Patients with Stage I Non-Small Cell Lung Cancer. Journal of Thoracic Oncology 2:1-7, 2007.
51. Huang EH, Liao Z, Cox JD, Guerrero TM, Chang JY, Jeter M, Borghero Y, Wei X, Fossella F, Herbst RS, Blumenschein GR, Moran C, Allen PK, Komaki R. Comparison of Outcomes for Patients with Unresectable Locally Advanced Non-Small-Cell Lung Cancer Treated with Induction Chemotherapy Followed by Concurrent Chemoradiation versus Concurrent Chemoradiation Alone. International Journal of Radiation Oncology Biology and Physics 68:779-786, 2007.
52. Bruzzi JF, Swisher SG, Truong MT, Munden RF, Hofstetter WL, Macapinlac HA, Correa AM, Mawlawi O, Ajani JA, Komaki RR, Fukami N, Erasmus JJ. Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy. Cancer 109:125-34, 2007.
53. Rice DC, Smythe WR, Liao Z, Guerrero T, Chang JY, McAleer MF, Jeter MD, Correa A, Vaporciyan AA, Liu HH, Komaki R, Forster KM, Stevens CW. Dose-Dependent Pulmonary Toxicity After Postoperative Intensity-Modulated Radiotherapy for Malignant Pleural Mesothelioma. Int J Radiat Oncol Biol Phys 69:350-357, 2007.
54. Zhao KL, Liao Z, Bucci MK, Komaki R, Cox JD, Yu ZH, Zhang L, Mohan R, Dong L. Evaluation of respiratory-induced target motion for esophageal tumors at the gastroesophageal junction. Radiotherapy and Oncology 84:283-289, 2007.
55. Rohatgi PR, Correa AM, Swisher SG, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Lee JH, Rice DC, Roth JA, Ajani JA. Gender-based analysis of esophageal cancer patients undergoing preoperative chemoradiation: differences in presentation and therapy outcome. Dis Esophagus 19:152-7, 2007. PMID: 16722991.
56. Klopp AH, Chang JY, Tucker SL, Sulman EP, Balter PA, Liu HH, Bucci MK, Macapinlac HA, Koamki, Cox JD. Intrathoracic Patterns of Failure for Non-Small Cell Lung Cancer with Positron Emission Tomography/ Computed Tomgraphy-Difined Target Delineation. International Journal of Radiation Oncology Biology and Physics 69:1409-1416, 2007.
57. Shioyama Y, Jang SY, Liu HH, Guerrero T, Wang X, Gayed IW, Erwin WD, Liao Z, Chang JY, Jeter M, Yaremko BP, Borghero YO, Cox JD, Komaki R, Mohan R. Preserving Functional Lung Using Perfusion Imaging and Intensity-Modulated Radiation Therapy for Advanced-Stage Non-Small-Cell Lung Cancer. Intl J Rad Oncol Biol Phys 68:1049-1058, 2007.
58. Hofstetter WL, Correa AM, Ajani JA, Phan A, Komaki R, Liao Z, Wu T-T, Blackmon S, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Proposed Modification of Nodal Status in AJCC esophageal cancer staging system. Annuals of Thoracic Surgery 84:365-375, 2007.
59. Rice,DC, Smyth RW, Liao Z,Guerrero T, Chang, JY, McAleer MF, Jeter MD, Correa A, Vaporcian AA, Lio HH, Komaki R, Forsater KM, Stevens CW. Pulmonary Toxicity Following Postoperative Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma. International Journal of Radiation Oncology Biology and Physics 69:350-357, 2007.
60. Guerrero T, Johnson V, Hart J, Pan T, Khan M, Luo D, Liao Z, Ajani J, Stevens C, Komaki R. Radiation pneumonitis: Local dose versus [(18)F]-fluorodeoxyglucose uptake response in irradiated lung. Int J Radiat Oncol Biol Phys 68:1030-1035, 2007.
61. Liao Z, Cox JD, Komaki R,. Radiochemotherapy of Esophageal Cancer. J Thor Oncol 2:553-568, 2007.
62. Shibuya K, Komaki R, Shintani T, Itasaka S, Ryan A, Jurgensmeier JM ,Milas L, Ang KK, Herbst RS, O’Reily MS. Targeted therapy against VEGFR and EGFR with ZD 6474 enhances the therapeutic efficacy of irradiation in orthotopic model of human non-small lung cancer. International Journal of Radiation Oncology Biology and Physics 69:1534-1543, 2007.
63. Wang S, Liao Z, Wei X, Liu HH, Tucker SL, Hu CS, Mohan R, Cox JD, Komaki R. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 66:1399-407, 12/2006.
64. Komaki R, Liao Z, Liu H, Tucker S, Rice D. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma: in regard to Allen et al. (Int J Radiat Oncol Biol Phys 2006;65:640-645). Int J Radiat Oncol Biol Phys 66:1595-6; author reply 1596, 12/2006. PMID: 17126220.
65. Erasmus JJ, Munden RF, Truong MT, Ho JJ, Hofstetter WL, Macapinlac HA, Correa AM, Wu T, Bruzzi JF, Marom EM, Sabloff BS, Ajani JA, Komaki R, Liao Z, Lee JH, Fukami N, Bresalier R, Swisher S. Pre-Operative Chemoradiation –Induced Ulceration in Patients with Esophageal Cancer: A Confounding Factor in Tumor Response Assessment in Integrated CT-PET Imaging. J Thor Oncol 1:478-486, 12/2006.
66. Tucker SL, Liu HH, Wang S, Wei X, Liao Z, Komaki R, Cox JD, Mohan R. Dose-volume modeling of the risk of postoperative pulmonary complications among esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 66:754-61, 11/2006. PMID: 16965865.
67. Klopp AH, Eapen GA, Komaki RR. Endobronchial brachytherapy: an effective option for palliation of malignant bronchial obstruction. Clin Lung Cancer 8:203-7, 11/2006. PMID: 17239296.
68. Sims-Mourtada J, Izzo JG, Apisarnthanarax S, Wu TT, Malhotra U, Luthra R, Liao Z, Komaki R, van der Kogel A, Ajani J, Chao KS. Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation response. Clin Cancer Res 12:6565-72, 11/2006. PMID: 17085672.
69. Gayed IW, Liu HH, Yusuf SW, Komaki R, Wei X, Wang X, Chang JY, Swafford J, Broemeling L, Liao Z. The prevalence of myocardial ischemia after concurrent chemoradiation therapy as detected by gated myocardial perfusion imaging in patients with esophageal cancer. J Nucl Med 47:1756-62, 11/2006. PMID: 17079807.
70. Wang KL, Yang Q, Cleary KR, Swisher SG, Correa AM, Komaki R, Ajani JA, Rashid A, Hamilton SR, Wu TT. The significance of neuroendocrine differentiation in adenocarcinoma of the esophagus and esophagogastric junction after preoperative chemoradiation. Cancer 107:1467-74, 10/2006. PMID: 16955509.
71. Fang LC, Komaki R, Allen P, Guerrero T, Mohan R, Cox JD. Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy. Int J Radiat Oncol Biol Phys 66:108-16, 9/2006. PMID: 16904517.
72. Wang SL, Liao Z, Liu HH, Ajani J, Swisher S, Cos J, Komaki R. Intensity-modulated radiation therapy with concurrent chemotherapy for locally advanced cervical and upper thoracic esophageal cancer. World J Gastroenterol 12(34):5501-8, 9/2006. PMID: 17006988.
73. Wang S, Liao Z, Liu H, Chen Y, Ajani J, Swisher S, Cox JD, Komaki R. Intensity-modulated radiotherapy (IMRT) with concurrent chemotherapy is an innnovative treatment modality for locally advanced cervical and upper thoracic esophageal cancer. World J Gastroenterol 34:5501-8, 9/2006.
74. Wang XS, Fairclough DL, Liao Z, Komaki R, Chang JY, Mobley GM, Cleeland CS. Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms. J Clin Oncol 24:4485-91, 9/2006. PMID: 16983118.
75. Wei X, Liu HH, Tucker SL, Liao Z, Hu C, Mohan R, Cox JD, Komaki R. Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66:100-7, 9/2006. PMID: 16839700.
76. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Wu TT, Swisher SG. The addition of induction chemotherapy to preoperative, concurrent chemoradiotherapy improves tumor response in patients with esophageal adenocarcinoma. Cancer 107:967-74, 9/2006. PMID: 16874819.
77. Lee JJ, Bekele BN, Zhou X, Cantor SB, Komaki R, Lee JS. Decision analysis for prophylactic cranial irradiation for patients with small-cell lung cancer. J Clin Oncol 24:3597-603, 8/2006. PMID: 16877726.
78. Ettinger DS, Bepler G, Bueno R, Chang A, Chang JY, Chirieac LR, D'Amico TA, Demmy TL, Feigenberg SJ, Grannis FW, Jr, Jahan T, Jahanzeb M, Kessinger A, Komaki R, Kris MG, Langer CJ, Le QT, Martins R, Otterson GA, Robert F, Sugarbaker DJ, Wood DE. Non-small cell lung cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw 4:548-82, 7/2006. PMID: 16813724.
79. Chang JY, Zhang X, Wang X, Kang Y, Riley B, Bilton S, Mohan R, Komaki R, Cox JD. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 65:1087-96, 7/2006. PMID: 16682145.
80. Chang JY, Moughan J, Johnstone DW, Komaki R, Goldberg M, Langer CJ, Beadle BM, Owen J, Movsas B. Surgical patterns of care in operable lung carcinoma treated with radiation. J Thorac Oncol 1(6):526-31, 7/2006. PMID: 17409912.
81. Erasmus JJ, Munden RF, Truong MT, Ho JJ, Hofstetter WL, Macapinlac HA, Correa AM, Wu TT, bruzzi JF, Marom EM, SAbloff BS, Ajani JA, Komaki R, Liao Z, Lee JH, Fukami N, Bresalier R, Swisher SG. Preoperative chemo-radiation-induced ulceration in patients iwth esophageal cancer: a confounding factor in tumor response assessment in integrated computed tomographis-positron emission tomographic imaging. J Thorac Onocl 1(5):478-86, 6/2006. PMID: 17409902.
82. Hu C, Chang EL, Hassenbusch SJ, 3rd, Allen PK, Woo SY, Mahajan A, Komaki R, Liao Z. Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis. Cancer 106(9):1998-2004, 5/2006. PMID: 16572401.
83. Chang JY, Zhang X, Komaki R, Cheung R, Fang B. Tumor-specific apoptotic gene targeting overcomes radiation resistance in esophageal adenocarcinoma. Int J Radiat Oncol Biol Phys 64(5):1482-94, 4/2006. PMID: 16580499.
84. Wang S, Liao Z, Chen Y, Chang JY, Jeter M, Guerrero T, Ajani J, Phan A, Swisher S, Allen P, Cox JD, Komaki R. Esophageal Cancer Located at the Neck and Upper Thorax Treated with Concurrent Chemoradiation: A Single-Institution Experience. J Thor Oncol 1:252-259, 3/2006.
85. Wang SL, Liao Z, Vaporciyan AA, Tucker SL, Liu H, Wei X, Swisher S, Ajani JA, Cox JD, Komaki R. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 64(3):692-9, 3/2006. PMID: 16242257.
86. Guerrero T, Castillo R, Sanders K, Price R, Komaki R, Cody D. Novel method to calculate pulmonary compliance images in rodents from computed tomography acquired at constant pressures. Phys Med Biol 51(5):1101-12, 3/2006. PMID: 16481680.
87. Liao Z, Liu H, Swisher SG, Wang L, Wu TT, Correa AM, Roth JA, Cox JD, Komaki R, Ajani JA, Wei Q. Polymorphism at the 3'-UTR of the thymidylate synthase gene: a potential predictor for outcomes in Caucasian patients with esophageal adenocarcinoma treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys 64(3):700-8, 3/2006. PMID: 16242255.
88. Gu Y, Swisher SG, Ajani JA, Correa AM, Hofstetter WL, Liao Z, Komaki RR, Rashid A, Hamilton SR, Wu TT. The number of lymph nodes with metastasis predicts survival in patients with esophageal or esophagogastric junction adenocarcinoma who receive preoperative chemoradiation. Cancer 106(5):1017-25, 3/2006. PMID: 16456809.
89. Guerrero T, Sanders K, Castillo E, Zhang Y, Bidaut L, Pan T, Komaki R. Dynamic ventilation imaging from four-dimensional computed tomography. Phys Med Biol 51(4):777-91, 2/2006. PMID: 16467578.
90. Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Rice DC, Bresalier RS, Roth JA, Ajani JA. Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy. Cancer 106(3):552-8, 2/2006. PMID: 16353210.
91. Malaisrie SC, Hofstetter WL, Correa AM, Ajani JA, Komaki RR, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Lahoti S, Lee JH, Bresalier R, Roth JA, Swisher SG. Endoscopic ultrasonography-identified celiac adenopathy remains a poor prognostic factor despite preoperative chemoradiotherapy in esophageal adenocarcinoma. J Thorac Cardiovasc Surg 131(1):65-72, 2006. PMID: 16399296.
92. Wang S, Bruzzi J, Rodriguez-Garza VP, Komaki RR. Lambert-eaton myasthenic syndrome in a patient with small-cell lung cancer. Clin Lung Cancer 7(4):282-4, 2006. PMID: 16512985.
93. Ettinger DS, Bepler G, Bueno R, Chang A, Chang JY, Chirieac LR, D'Amico TA, Demmy TL, Feigenberg SJ, Grannis Jr FW, Jahan T, Jahanzeb M, Kessinger A, Komaki R, Kris MG, Langer CJ, Le QT, Martins R, Otterson GA, Robert F, Sugarbaker DJ, Wood DE. Non-small cell lung cancer: Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 4(6):548-582, 2006.
94. Chang JY, Moughan J, Johnstone DW, Komaki R, Goldberg M, Langer CJ, Beadle BM, Owen J, Movsas B. Surgical patterns of care in operable lung carcinoma treated with radiation. Journal of Thoracic Oncology 1:526-531, 2006.
95. Rohatgi P, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh GL, Vaporciyan AA, Rice DC, Roth JA, Ajani JA. Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response. Cancer 104:2365-72, 12/2005. PMID: 16245310.
96. Chandra A, Guerrero TM, Liu HH, Tucker SL, Liao Z, Wang X, Murshed H, Bonnen MD, Garg AK, Stevens CW, Chang JY, Jeter MD, Mohan R, Cox JD, Komaki R. Feasibility of using intensity-modulated radiotherapy to improve lung sparing in treatment planning for distal esophageal cancer. Radiother Oncol 77(3):247-53, 12/2005. PMID: 16298001.
97. Martin LW, Correa AM, Hofstetter W, Hong WK, Komaki R, Putnam JB, Jr, Rice DC, Smythe WR, Swisher SG, Vaporciyan AA, Walsh GL, Roth JA. The evolution of treatment outcomes for resected stage IIIA non-small cell lung cancer over 16 years at a single institution. J Thorac Cardiovasc Surg 130(6):1601-10, 12/2005. PMID: 16308005.
98. Machtay M, Hsu C, Komaki R, Sause WT, Swann RS, Langer CJ, Byhardt RW, Curran WJ. Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience. Int J Radiat Oncol Biol Phys 63:667-71, 11/2005. PMID: 15927409.
99. Rohatgi PR, Swisher SG, Correa AM, Wu TT, Liao Z, Komaki R, Walsh G, Vaporciyan A, Lynch PM, Rice DC, Roth JA, Ajani JA. Failure patterns correlate with the proportion of residual carcinoma after preoperative chemoradiotherapy for carcinoma of the esophagus. Cancer 104(7):1349-55, 10/2005. PMID: 16130133.
100. Hong D, Lunagomez S, Kim EE, Lee JH, Bresalier RS, Swisher SG, Wu TT, Morris J, Liao Z, Komaki R, Ajani JA. Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma. Cancer 104(8):1620-6, 10/2005. PMID: 16118804.
101. Komaki R. What should the optimal timing be for amifostine administration relative to radiation and chemotherapy? J Clin Oncol 23(28):7232-3; author reply 7233-5, 10/2005. PMID: 16192612.
102. Zhang X, Cheung RM, Komaki R, Fang B, Chang JY. Radiotherapy sensitization by tumor-specific TRAIL gene targeting improves survival of mice bearing human non-small cell lung cancer. Clin Cancer Res 11(18):6657-68, 9/2005. PMID: 16166445.
103. Chang JY, Liu HH, Komaki R. Intensity modulated radiation therapy and proton radiotherapy for non-small cell lung cancer. Curr Oncol Rep 7(4):255-9, 7/2005. PMID: 15946583.
104. Guerrero T, Sanders K, Noyola-Martinez J, Castillo E, Zhang Y, Tapia R, Guerra R, Borghero Y, Komaki R. Quantification of regional ventilation from treatment planning CT. Int J Radiat Oncol Biol Phys 62(3):630-4, 7/2005. PMID: 15936537.
105. Komaki R, Swann RS, Ettinger DS, Glisson BS, Sandler AB, Movsas B, Suh J, Byhardt RW. Phase I study of thoracic radiation dose escalation with concurrent chemotherapy for patients with limited small-cell lung cancer: Report of Radiation Therapy Oncology Group (RTOG) protocol 97-12. Int J Radiat Oncol Biol Phys 62(2):342-50, 6/2005. PMID: 15890573.
106. Wakelee HA, Stephenson P, Keller SM, Wagner H, Herskovic A, Komaki R, Marks RS, Perry MC, Livingston RB, Johnson DH. Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIA non-small cell lung cancer (NSCLC) does not increase the expected risk of death from intercurrent disease (DID) in Eastern Cooperative Oncology Group (ECOG) trial E3590. Lung Cancer 48(3):389-97, 6/2005. PMID: 15893008.
107. Liao Z, Komaki R, Milas L, Yuan C, Kies M, Chang JY, Jeter M, Guerrero T, Blumenschien G, Smith CM, Fossella F, Brown B, Cox JD. A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer. Clin Cancer Res 11(9):3342-8, 5/2005. PMID: 15867233.
108. Agarwal B, Swisher SG, Ajani J, Kelly K, Komaki RR, Abu-Hamda E, Correa AM, Roth JA. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux. Ann Thorac Surg 79(5):1716-23, 5/2005. PMID: 15854962.
109. Bradley JD, Paulus R, Graham MV, Ettinger DS, Johnstone DW, Pilepich MV, Machtay M, Komaki R, Atkins J, Curran WJ. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705. J Clin Oncol 23(15):3480-7, 5/2005. PMID: 15908657.
110. Swisher SG, Hofstetter W, Wu TT, Correa AM, Ajani JA, Komaki RR, Chirieac L, Hunt KK, Liao Z, Phan A, Rice DC, Vaporciyan AA, Walsh GL, Roth JA. Proposed revision of the esophageal cancer staging system to accommodate pathologic response (pP) following preoperative chemoradiation (CRT). Ann Surg 241(5):810-7; discussion 817-20, 5/2005. PMID: 15849517.
111. Chang JY, Komaki R, Sasaki R, Liao Z, Stevens CW, Lu C, Fossella FV, Allen PK, Cox JD, Spitz MR, Wu X. High mutagen sensitivity in peripheral blood lymphocytes predicts poor overall and disease-specific survival in patients with stage III non-small cell lung cancer treated with radiotherapy and chemotherapy. Clin Cancer Res 11(8):2894-8, 4/2005. PMID: 15837739.
112. Komaki R, Chang JY, Wu X, Allen PK, Milas L, Liao Z, Fossella FV, Travis E, Spitz MR. Mutagen sensitivity may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer treated by chemoradiotherapy. Semin Oncol 32(Suppl 3):S92-S98, 4/2005. PMID: 16015542.
113. Langer CJ, Moughan J, Movsas B, Komaki R, Ettinger D, Owen J, Wilson JF. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature? Lung Cancer 48(1):93-102, 4/2005. PMID: 15777975.
114. Chirieac LR, Swisher SG, Ajani JA, Komaki RR, Correa AM, Morris JS, Roth JA, Rashid A, Hamilton SR, Wu TT. Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer 103(7):1347-55, 4/2005. PMID: 15719440.
115. Movsas B, Scott C, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Smith C, Axelrod R, Sarna L, Wasserman T, Byhardt R. Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: radiation therapy oncology group trial 98-01. J Clin Oncol 23(10):2145-54, 4/2005. PMID: 15800308.
116. Zhang Z, Liao Z, Jin J, Ajani J, Chang JY, Jeter M, Guerrero T, Stevens CW, Swisher S, Ho L, Yao J, Allen P, Cox JD, Komaki R. Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys 61(3):656-64, 3/2005. PMID: 15708243.
117. Chirieac LR, Swisher SG, Correa AM, Ajani JA, Komaki RR, Rashid A, Hamilton SR, Wu TT. Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma. Clin Cancer Res 11(6):2229-36, 3/2005. PMID: 15788671.
118. Sasaki R, Komaki R, Macapinlac H, Erasmus J, Allen P, Forster K, Putnam JB, Herbst RS, Moran CA, Podoloff DA, Roth JA, Cox JD. [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. J Clin Oncol 23(6):1136-43, 2/2005. PMID: 15718309.
119. Rice DC, Correa AM, Vaporciyan AA, Sodhi N, Smythe WR, Swisher SG, Walsh GL, Putnam JB, Jr, Komaki R, Ajani JA, Roth JA. Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity. Ann Thorac Surg 79(2):391-7; discussionn 391-7, 2/2005. PMID: 15680801.
120. Bradley J, Graham MV, Winter K, Purdy JA, Komaki R, Roa WH, Ryu JK, Bosch W, Emami B. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 61(2):318-28, 2/2005. PMID: 15667949.
121. Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB, Jr, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Int J Radiat Oncol Biol Phys 60(5):1484-93, 12/2004. PMID: 15590179.
122. Koch N, Liu HH, Starkschall G, Jacobson M, Forster K, Liao Z, Komaki R, Stevens CW. Evaluation of internal lung motion for respiratory-gated radiotherapy using MRI: Part I--correlating internal lung motion with skin fiducial motion. Int J Radiat Oncol Biol Phys 60(5):1459-72, 12/2004. PMID: 15590177.
123. Liu HH, Koch N, Starkschall G, Jacobson M, Forster K, Liao Z, Komaki R, Stevens CW. Evaluation of internal lung motion for respiratory-gated radiotherapy using MRI: Part II-margin reduction of internal target volume. Int J Radiat Oncol Biol Phys 60(5):1473-83, 12/2004. PMID: 15590178.
124. Swisher SG, Erasmus J, Maish M, Correa AM, Macapinlac H, Ajani JA, Cox JD, Komaki RR, Hong D, Lee HK, Putnam JB, Jr, Rice DC, Smythe WR, Thai L, Vaporciyan AA, Walsh GL, Wu TT, Roth JA. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer 101(8):1776-85, 10/2004. PMID: 15386332.
125. Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J, Jr, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 60(2):427-36, 10/2004. PMID: 15380576.
126. Arriagada R, Komaki R, Cox JD. Radiation dose escalation in non-small cell carcinoma of the lung. Semin Radiat Oncol 14(4):287-91, 10/2004. PMID: 15558502.
127. Swisher SG, Maish M, Erasmus JJ, Correa AM, Ajani JA, Bresalier R, Komaki R, Macapinlac H, Munden RF, Putnam JB, Rice D, Smythe WR, Vaporciyan AA, Walsh GL, Wu TT, Roth JA. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Ann Thorac Surg 78(4):1152-60; discussion 1152-60, 10/2004. PMID: 15464463.
128. Agarwal B, Swisher S, Ajani J, Kelly K, Fanning C, Komaki RR, Putnam JB, Jr, Abu-Hamda E, Molke KL, Walsh GL, Correa AM, Ho L, Liao Z, Lynch PM, Rice DC, Smythe WR, Stevens CW, Vaporciyan AA, Yao J, Roth JA. Endoscopic ultrasound after preoperative chemoradiation can help identify patients who benefit maximally after surgical esophageal resection. Am J Gastroenterol 99(7):1258-66, 7/2004. PMID: 15233663.
129. Keller SM, Vangel MG, Wagner H, Schiller JH, Herskovic A, Komaki R, Marks RS, Perry MC, Livingston RB, Johnson DH. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease. J Thorac Cardiovasc Surg 128(1):130-7, 7/2004. PMID: 15224032.
130. Kim ES, Putnam JB, Komaki R, Walsh GL, Ro JY, Shin HJ, Truong M, Moon H, Swisher SG, Fossella FV, Khuri FR, Hong WK, Shin DM. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Lung Cancer 44(3):369-79, 6/2004. PMID: 15140551.
131. Ajani JA, Walsh G, Komaki R, Morris J, Swisher SG, Putnam JB, Jr, Lynch PM, Wu TT, Smythe R, Vaporciyan A, Faust J, Cohen DS, Nivers R, Roth JA. Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction. Cancer 100(11):2347-54, 6/2004. PMID: 15160337.
132. Andratschke NH, Dittmann KH, Mason KA, Fan Z, Liao Z, Komaki R, Ang KK, Milas L. Epidermal growth factor receptor as a target to improve treatment of lung cancer. Clin Lung Cancer 5(6):340-52, 5/2004. PMID: 15217533.
133. Komaki R, Lee JS, Milas L, Lee HK, Fossella FV, Herbst RS, Allen PK, Liao Z, Stevens CW, Lu C, Zinner RG, Papadimitrakopoulou VA, Kies MS, Blumenschein GR, Jr, Pisters KM, Glisson BS, Kurie J, Kaplan B, Garza VP, Mooring D, Tucker SL, Cox JD. Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial. Int J Radiat Oncol Biol Phys 58(5):1369-77, 4/2004. PMID: 15050312.
134. Murshed H, Liu HH, Liao Z, Barker JL, Wang X, Tucker SL, Chandra A, Guerrero T, Stevens C, Chang JY, Jeter M, Cox JD, Komaki R, Mohan R. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58(4):1258-67, 3/2004. PMID: 15001271.
135. Liu HH, Wang X, Dong L, Wu Q, Liao Z, Stevens CW, Guerrero TM, Komaki R, Cox JD, Mohan R. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58(4):1268-79, 3/2004. PMID: 15001272.
136. Komaki R, Liao Z, Milas L. Improvement strategies for molecular targeting: Cyclooxygenase-2 inhibitors as radiosensitizers for non-small cell lung cancer. Semin Oncol 31(1 Suppl 1):47-53, 2/2004. PMID: 14981580.
137. Butler LE, Forster KM, Stevens CW, Bloch C, Liu HH, Tucker SL, Komaki R, Liao Z, Starkschall G. Dosimetric benefits of respiratory gating: a preliminary study. J Appl Clin Med Phys 5(1):16-24, 2004. PMID: 15753930.
138. Taylor NA, Liao ZX, Cox JD, Stevens C, Roth J, Walsh G, Chang JY, Guerrero T, Jeter M, Putnam J, Jr, Fossella FV, Allen P, Komaki R. Equivalent outcome of patients with clinical Stage IIIA non-small-cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resection. Int J Radiat Oncol Biol Phys 58(1):204-12, 2004. PMID: 14697440.
139. Brooks C, Starkschall G, Famiglietti R, Cox J, Frank S, Komaki R, Liao Z, Stevens C, Forster K. Heterogeneous planning for homogeneous protocols. Med Dosim 29(2):80-4, 2004. PMID: 15191752.
140. Cox JD, Le Chevalier T, Arriagada R, Choy H, Curran WJ, Fukuoka M, Harper P, Komaki R, Le Pechoux C, Lievens Y, Rami-Porta R, Ready N, Sause W, Stuschke M, Thatcher N. Management of unresectable non-small cell carcinoma of the lung (NSCLC). Lung Cancer 42 Suppl 1:S15-6, 12/2003. PMID: 14708518.
141. Lee HK, Vaporciyan AA, Cox JD, Tucker SL, Putnam JB, Jr, Ajani JA, Liao Z, Swisher SG, Roth JA, Smythe WR, Walsh GL, Mohan R, Liu HH, Mooring D, Komaki R. Postoperative pulmonary complications after preoperative chemoradiation for esophageal carcinoma: correlation with pulmonary dose-volume histogram parameters. Int J Radiat Oncol Biol Phys 57(5):1317-22, 12/2003. PMID: 14630268.
142. Movsas B, Moughan J, Komaki R, Choy H, Byhardt R, Langer C, Goldberg M, Graham M, Ettinger D, Johnstone D, Abrams R, Munden R, Starkschall G, Owen J. Radiotherapy patterns of care study in lung carcinoma. J Clin Oncol 21(24):4553-9, 12/2003. PMID: 14597743.
143. Ahamad A, Stevens CW, Smythe WR, Liao Z, Vaporciyan AA, Rice D, Walsh G, Guerrero T, Chang J, Bell B, Komaki R, Forster KM. Promising early local control of malignant pleural mesothelioma following postoperative intensity modulated radiotherapy (IMRT) to the chest. Cancer J 9(6):476-84, 11/2003. PMID: 14740977.
144. Keller SM, Vangel MG, Wagner H, Schiller J, Herskovic A, Komaki R, Gray R, Marks RS, Perry MC, Livingston RB, Johnson DH. Second primary tumors following adjuvant therapy of resected stages II and IIIa non-small cell lung cancer. Lung Cancer 42(1):79-86, 10/2003. PMID: 14512191.
145. Ajani JA, Faust J, Yao J, Komaki R, Stevens C, Swisher S, Putnam JB, Vaporciyan A, Smythe R, Walsh G, Rice D, Roth J. Irinotecan/cisplatin followed by 5-FU/paclitaxel/radiotherapy and surgery in esophageal cancer. Oncology (Williston Park) 17(9 Suppl 8):20-2, 9/2003. PMID: 14569843.
146. Swisher SG, Ajani JA, Komaki R, Nesbitt JC, Correa AM, Cox JD, Lahoti S, Martin F, Putnam JB, Smythe WR, Vaporciyan AA, Walsh GL, Roth JA. Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 57(1):120-7, 9/2003. PMID: 12909224.
147. Liao Z, Milas L, Komaki R, Stevens C, Cox JD. Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer. Am J Clin Oncol 26(4):S85-91, 8/2003. PMID: 12902863.
148. Komaki R. Combined treatment for limited small cell lung cancer. Semin Oncol 30(4 Suppl 9):56-70, 8/2003. PMID: 12908137.
149. Frank SJ, Forster KM, Stevens CW, Cox JD, Komaki R, Liao Z, Tucker S, Wang X, Steadham RE, Brooks C, Starkschall G. Treatment planning for lung cancer: traditional homogeneous point-dose prescription compared with heterogeneity-corrected dose-volume prescription. Int J Radiat Oncol Biol Phys 56(5):1308-18, 8/2003. PMID: 12873675.
150. Johnson FM, Kurie JM, Peeples BO, Pisters KM, Fossella FV, Papadimitrakopoulou VA, Blumenschein GR, Komaki R, Glisson BS. Dose-dense therapy with a novel irinotecan regimen for small-cell lung cancer. Oncology (Williston Park) 17(7 Suppl 7):17-21, 7/2003. PMID: 12886869.
151. Johnson FM, Kurie JM, Peeples BO, Lee JJ, Feng L, Pisters KM, Fossella FV, Papadimitrakopoulou VA, Blumenschein GR, Komaki R, Glisson BS. Phase I study of weekly alternating therapy with irinotecan/cisplatin and etoposide/cisplatin for patients with small-cell lung cancer. Clin Lung Cancer 5(1):40-5, 7/2003. PMID: 14596703.
152. Taylor NA, Liao ZX, Stevens C, Walsh G, Roth J, Putnam J, Jr, Fossella F, Allen P, Cox JD, Komaki R. Postoperative radiotherapy increases locoregional control of patients with stage IIIA non-small-cell lung cancer treated with induction chemotherapy followed by surgery. Int J Radiat Oncol Biol Phys 56(3):616-25, 7/2003. PMID: 12788166.
153. Mehta MP, Rodrigus P, Terhaard CH, Rao A, Suh J, Roa W, Souhami L, Bezjak A, Leibenhaut M, Komaki R, Schultz C, Timmerman R, Curran W, Smith J, Phan SC, Miller RA, Renschler MF. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol 21(13):2529-36, 7/2003. PMID: 12829672.
154. Lu C, Komaki R, Lee JS, Shin DM, Palmer JL, Coldman BJ, Pisters KM, Kurie JM, Fossella FV, Glisson BS. A phase I study of topotecan/paclitaxel alternating with etoposide/cisplatin and thoracic irradiation in patients with limited small cell lung cancer. Clin Cancer Res 9(6):2085-91, 6/2003. PMID: 12796372.
155. Gopal R, Starkschall G, Tucker SL, Cox JD, Liao Z, Hanus M, Kelly JF, Stevens CW, Komaki R. Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 56(1):114-20, 5/2003. PMID: 12694829.
156. Liao Z, Komaki R, Mason KA, Milas L. Role of cyclooxygenase-2 inhibitors in combination with radiation therapy in lung cancer. Clin Cancer Research 4(6):356-65, 5/2003. PMID: 14599301.
157. Gopal R, Tucker SL, Komaki R, Liao Z, Forster KM, Stevens C, Kelly JF, Starkschall G. The relationship between local dose and loss of function for irradiated lung. Int J Radiat Oncol Biol Phys 56(1):106-13, 5/2003. PMID: 12694828.
158. Milas I, Komaki R, Hachiya T, Bubb RS, Ro JY, Langford L, Sawaya R, Putnam JB, Allen P, Cox JD, McDonnell TJ, Brock W, Hong WK, Roth JA, Milas L. Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases. Clin Cancer Res 9(3):1070-6, 3/2003. PMID: 12631609.
159. Ahamad A, Stevens CW, Smythe WR, Vaporciyan AA, Komaki R, Kelly JF, Liao Z, Starkschall G, Forster KM. Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 55(3):768-75, 3/2003. PMID: 12573764.
160. Forster KM, Smythe WR, Starkschall G, Liao Z, Takanaka T, Kelly JF, Vaporciyan A, Ahamad A, Dong L, Salehpour M, Komaki R, Stevens CW. Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation. Int J Radiat Oncol Biol Phys 55(3):606-16, 3/2003. PMID: 12573747.
161. Swisher SG, Roth JA, Komaki R, Gu J, Lee JJ, Hicks M, Ro JY, Hong WK, Merritt JA, Ahrar K, Atkinson NE, Correa AM, Dolormente M, Dreiling L, El-Naggar AK, Fossella F, Francisco R, Glisson B, Grammer S, Herbst R, Huaringa A, Kemp B, Khuri FR, Kurie JM, Liao Z, McDonnell TJ, Morice R, Morello F, Munden R, Papadimitrakopoulou V, Pisters KM, Putnam JB, Jr, Sarabia AJ, Shelton T, Stevens C, Shin DM, Smythe WR, Vaporciyan AA, Walsh GL, Yin M. Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN 201) and radiation therapy. Clin Cancer Res 9(1):93-101, 2003. PMID: 12538456.
162. Kaplan B, Stevens CW, Allen P, Liao Z, Komaki R. Outcomes and patterns of failure in bronchial carcinoid tumors. Int J Radiat Oncol Biol Phys 55(1):125-31, 2003. PMID: 12504044.
163. Komaki R, Liao Z, Foster K, Lee H, Stevens C, Cox J. Target Definition and contouring in Carcinoma of the Lung and Esophagus. RAYS 28(3):225-236, 2003.

Invited Articles
1. Komaki R. National Comprehensive Cancer Network (NCCN): Non-Small Cell Lung Cancer Guidelines. Expert Panel Member CD ROM, 2007.
2. Komaki R. Comprehensive Cancer Network (NCCN): Non-Small Cell Lung Cancer Guidelines. Expert Panel Member CD ROM, 2006.
3. Yang Q, Cleary KR, Yao JC, Swisher SG, Roth JA, Lynch PM, Komaki R, Ajani JA, Rashid A, Hamilton SR, Wu TT. Significance of post-chemoradiation biopsy in predicting residual esophageal carcinoma in the surgical specimen. Dis Esophagus 17(1):38-43, 2004. PMID: 15209739.
4. Komaki R, Liao Z, Forster K, Lee HK, Stevens CW, Cox JD. Target definition and contouring in carcinoma of the lung and esophagus. Rays 28(3):225-36, 7/2003. PMID: 15018311.
5. Sanders KE, Komaki R, Buchholz TA. Target delineation and treatment planning in breast conserving therapy. Rays 28(3):237-45, 7/2003. PMID: 15018312.
6. Cox JD, Schechter NR, Lee AK, Forster K, Stevens CW, Ang KK, Komaki R, Liao Z, Milas L. Uncertainties in physical and biological targeting with radiation therapy. Rays 28(3):211-5, 7/2003. PMID: 15018309.
7. Komaki R. Aggressive palliative radiotherapy for a patient with a malignant superior sulcus tumor and adrenal metastasis. A case report. . The Lung Quarterly Scan 4(4):3, 2003.

Abstracts
1. Bucci MK, Ezhil M, Vedam S, Choi B, Dong L, McAleer MF, Munsell M, Komkai R, Balter P. 4D CT-Derived PTV Spares Normal Lung Volume Compared to Free Breathing CT-Derived PTV for Both Early and Late Stage Non-Samll Cell Lung Cancer Patients. A Supplement to Oncology 22(Suppl 1):17, 2008.
2. Chang JY, Balter P,Dong L, Liao Z,Bucci KM,Jeter M, McAleer ,Yang Q, Cox JD, Komaki R. 4D CT Based and Daily In-Room CT-guided Stereotactic Body Radiotherapy (SBRT) in Lung Cancer. Proceedings of ASTRO 69:88S, 2007.
3. Swisher S, Winters K, Komaki R, Ajani J, T. Wu T, W. Hofstetter W, A. Konski,. Willett.C. A Phase II Study of a Paclitaxel Based Chemoradiation Regimen with Selective Surgical Salvage for Resectable Locoregionally Advanced Esophageal Cancer: Initial Reporting of RTOG 0246. Proceeding of ASTRO 69:106S, 2007.
4. Blumenschein Jr G, Moughan J, Curran W, Robert F, Fossella F, Werner-Wasik M, Doescher P, Choy H, Komaki R. A phase II study of cetuximab (C225) in combinaton with cheomradiation (CRT) in patients (pts) with stage III A/B non-small cell lunc cancer (NSCLC): An interim report of the RTOG 0324 trial. Proceedings of ASCO 25:392S, 2007.
5. Lu C, Lee JJ, Komaki R, Herbst RS, Evan WK, Choy H, Desjardins P, Esparaz BT, Truong M, Fisch MJ. A phase III study of /E-941 with induction cheomtherapy (IC) and concomitant chemoradiotherapy (CRT) for stage III non-small cell lung cancer (NSCLC) (NCI T99-0046, RTOG 02-07, MDA 99-303. Proceedings of ASCO 25:391S, 2007.
6. Liao Z, Cox JD, Liu H, Komaki R,Tucker SL, Mohan R, Martel M, Allen PK, Thames HD. Assessing The Impact Of Technological Advancement On Outcome For Patients With Unresectable Locally Advanced Non-small-cell Lung Cancer (nsclc) Receiving Concomitant Chemoradiotherapy. Proceedings of ASTRO 69:160S, 2007.
7. Wei X,. Komaki R, Allen PK, Garza VP, Liao Z, Chang JY, Guerrero TM, Bilton S, Cox JD. EFFECTS OF AMIFOSTINE ON ACUTE AND LATE TOXICITY OF once daily and twice daily RADIOTHERAPY AND CONCURRENT CHEMOTHERAPY FOR LOCAL ADVANCED NON-SMALLCELL LUNG CANCER. Proceedings of ASTRO 69:476S, 2007.
8. McGovern SL, Liao Z, Bucci K, McAleer MF, Jeter MD, Chang JY, Huang EH, Cox JD, Allen PK, Komaki R. Gender Differences in NSCLC Outcomes. Proceedings of ASTRO 69:160S, 2007.
9. Komaki, Ritsuko R. A Randomized Phase II Study of two paclitaxel based chemoradiotherapy for patients with the non-operative esophageal cancer. ASTRO, 11/2006.
10. Huang HH, Liao Z, Cox JD, Wei X, Komaki R. Comparison of outcomes for locally advanced inoperable non-small cell lung cancer treated using concuurent chemoradiation with vs. without induction chemotherapy. Proc American Radium Society 20 - Suppl 3:20, 4/2006.
11. Komaki, Ritsuko R. Comparison of outcomes for patients with medically inoperable stage I non-small cell lung cancer treated with two-dimensional vs. three dimensional radiotherapy. Proc American Radium Society 20 - Suppl 3:20, 4/2006.
12. Yaremko B, Guerrero T, Harvey M, Komaki R. Pulmonary function imaging from four-dimensional computed tomography for radiation oncology. Proc American Radium Society 20 - suppl 3:24, 4/2006.
13. Torres MA, Guerrero T, Castillo R, Cody D, Komaki R, Travis EL. Raduction of pulmonary compliance in mice following thoracic radiation. Proc American Radium Society 20 - suppl 3:47, 4/2006.
14. Komaki R. A Randomized Phase II Study of two paclitaxel based chemoradiotherapy for patients with the non-operative esophageal cancer. Proceedings of ASTRO 66:327, 2006.
15. Huang HH, Liao Z, Cox JD, Wei X, Komaki R. Comparison of outcomes for locally advanced inoperable non-small cell lung cancer treated using concuurent chemoradiation with vs. without induction chemotherapy. Proceedings American Radium Society Suppl 3:20S, 2006.
16. Komaki R. Comparison of outcomes for patients with medically inoperable stage I non-small cell lung cancer treated with two-dimensional vs. three dimensional radiotherapy. Proceedings American Radium Society Suppl 3:20S, 2006.
17. Curran W, Scott C, Langer C, Komaki R, Lee J, Hauser S, Movsas B, Wasserman T, Sause W, Cox J. Long-term benefit is observed in a phase III comparison of sequential vs concurrent chemo-radiation for patients with unresected stage III NSCLC: RTOG 94-10. J Clin Oncol 22:621 (#2499), 2006.
18. Yaremko B, Guerrero T, Harvey M, Komaki R. Pulmonary function imaging from four-dimensional computed tomography for radiation oncology. Proceedings American Radium Society Suppl 3:24S, 2006.
19. Liao Z, Komaki R, Milas L, Chen Y, Kies M, Chang J, Jeter M, Guerrero T, Blumenschein G, Cox J. A dose escalation clinical trial using thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperabe/unresectable non-small cell lung cancer (NSCLC). Proc of IASLC. Lung Cancer 49(Suppl 2):S372 (#P-959), 2005.
20. Blumenschein G, Swann S, Curran W, Robert F, Werner-Wasik M, Lee C, Jafar S, Shara R, Choy H, Komaki R. A pase II study of cetuximab (C225) in combination with chemoradiation (CRT) in patients (PTS) with stage IIIA/B non-small cell lung cancer (NSCLC): An interim overall toxicity report of the RTOG 0324 trial. Proc of IASLC. Lung Cancer 49(Suppl 2):S78 (#PD-039), 2005.
21. Werner-Wasik M, Swann S, Curran W, Robert F, Komaki R, Lee CP, Jafar S, Share R, Choy H, Blumenschein G. A phase II study of cetuximab (C225) in combination with chemoradiation (CRT) in patients (PTS) with stage IIIA/B non-small cell lung cancer (NSCLC): An interim overall toxicity report of the RTOG 0324 trial. Proc ASCO 23:654s (#7135), 2005.
22. Lu C, Komaki R, Herbst RS, Evans WK, Lee JJ, Truong M, Moore CA, Choy H, Bleyer A, Fisch MJ. A phase III sudy of AE-941 with induction chemotherapy (IC) and concomitant chemoradiotherapy (CRT) for stage III non-small cell lung cancer (NSCLC) (NCI T99-0046, RTOG 02-70, MDA 99-303): An interim report of toxicity and response. Proc ASCO 23:656s (#7144), 2005.
23. Yom S, Liao Z, Liu H, Allen P, Chang J, Jeter M, Guerrero T, Stevens C, Cox J, Komaki R. Analysis of acute toxicity results of intensity modulated (IMRT) in the treatment of non-small cell lung cancer (NSCLC). Proc of IASLC. Lung Cancer 49(Suppl 2):S52 (#O-152), 2005.
24. Fang CL, Komaki R, Allen P, Guerrero T, Mohan R, Cox J. Comparison of outcomes for patients with medically inoperable stage I non-small cell lung cancer treated with two-dimensional versus three-dimensional radiotherapy. Proc of IASLC. Lung Cancer 49(Suppl 2):S49 (#O-142), 2005.
25. Komaki R, Swann S, Byhardt R, Cox J, Scot C, Sause W. Does response rate in the induction chemotherapy predict survival for locally advanced non-small cell lung cancer (LANSCLC)? Secondary analysis of RTOG 8804/8808. Proc of IASLC. Lung Cancer 49(Suppl 2):S88 (#PD-074), 2005.
26. Komaki R, Allen P, Glisson B, Lu C, Fossella F, Liao Z, Jeter M, Stevens C, Chang J, Guerrero G, Blumenschein G. Hyperfractionated/accelerated thoracic radiation therapy (HFXRT) increased survival compared to daily RT (QDRT) for limited small cell lung cancer (LSCLC) with concurrent chemotherapy (ChT). Proc ASCO 23:659s (#7158), 2005.
27. Chang J, Dong L, Mohan R, Liao Z, Cox J, Komaki R. Image-guided proton radiotherapy for medically inoperable stage I non-small cell lung cancer. Proc of IASLC. Lung Cancer 49(Suppl 2):S93 (#PD-088), 2005.
28. Swann RS, Machtay M, Komaki R, Sause WT, Langer CJ, Byhardt RW, Curran WJ. Impact of overall treatment time during concurrent chemoradiotherapy for locally advanced NSCLC: An RTOG secondary analysis. Proc ASCO 23:635s (#7061), 2005.
29. Basir S, Fossella F, Hwang L, Lu C, Komaki R, Zinner R. Loco-regional progression after induction chemotherapy may predict the development of M1 disease after the initiation of concurrent chemo-radiation in stage III NSCLC. Proc of IASLC. Lung Cancer 49(Suppl 2):S77 (#PD-036), 2005.
30. Gu Y, Swisher SG, Ajani JA, Correa AM, Hofstetter W, Liao Z, Komaki R, Rashid A, Hamilton SR, Wu T-T. Number of lymph nodes with metastasis predict survival in patients with esophageal or esophagogastric junction adenocarcinoma treated with preoperative chemoradiation. Proc ASCO 23:319s (#4046), 2005.
31. Komaki R, Allen P, Roth J, Swisher S, Rice D, Fossella F, Herbst R, Oh Y, Munden R, Cox J. Optimal treatment for superior sulcus tumors (SST): Surgery first followed by adjunct RT/ChT improved survival for patients with resectable SST. Proc of IASLC. Lung Cancer 49;Suppl 2:S79 (#PD-044), 2005.
32. Machtay M, Swann S, Komaki R, Sause W, Langer C, Byhardt R, Curran W. Overall treatment time during concurrent chemoradiotherapy and outcomes: An RTOG secondary analysis. Proc of IASLC. Lung Cancer 49(Suppl 2):S17 (#O-042), 2005.
33. Guerrero T, Sanders K, Castillo R, Ribera B, Cody D, Price RBidaut L, Komaki R. Pulmonary compliance imaging in rodents. Proc BioMech, 2005.
34. Machtay M, Swann S, Komaki R, Byhardt R, Paulus R, Sause W, Curran W, Albain K, Movsas B. What is the meaning of local-regional control after chemoradiation for locally advanced NSCLC? An RTOG analysis . Proc of IASLC. Lung Cancer 49(Suppl 2):S17 (#O-041), 2005.
35. Komaki R. Cytoprotection and target volume definition based on PET/CT. The 4th Takahashi Memorial International Workshop on 3 Dimensional Conformal Radiotherapy, Nagoya Japan, 98-99, 2004.
36. Komaki R, Allen PGlisson B, Milas L, Charles L, Kaplan B, Fossella F, Liao Z, Jeter M, Stevens C, Chang J, Guerrero T. Hyperfractionated and accelerated thoracic radiation therapy (HFXATRT) increased survival compared to daily TRT (QDTRT) for limited small cell lung cancer (LSCLC) patients treated with concurrent chemotherapy. Proc ASTRO 60:S203 (#123), 2004.
37. Swisher SG, Ajani JA, Chirieac L, Vaporciyan AA, Wu TT, Hunt KK, Correa AM, Komaki R, Rice DC, Walsh GL, Roth JA. Impract of pathologic response on pTNM esophageal cancer staging system following preoperative chemoradiation (CRT). Proceedings of 116th Meeting of the Southern Surgical Association, Palm Beach FL, 55-5, 2004.
38. Liao Z, Chen Y, Komaki R, Cox JD, Milas L. A phase I study combining thoracic radiation (RT) with celecoxib in patients with non-small cell lung cancer (NSCLC). Proceedings ASCO 22:216 (#867), 2003.
39. Lu C, Komaki R, Herbst RS, Evans WK, Smith TL, Moore CA, Kilbye SL, Choi NC, Choy H, Bleyer A. A phase III study of AE-941 (Neovastat) with induction chemotherapy (IC) and concomitant chemoradiotehrapy (CRT) for stage III non-small cell lung cancer (NSCLC) (NCI T99-0046, RTOG 02-70, MDA 99-303): An interim analysis of toxicity and response. Lung Cancer 42(Suppl 2):S90, 2003.
40. Bradley JD, Graham MV, Winter KW, Purdy JA, Komaki R, Roa WH, Ryu JK, Bosch W, Emami B. Acute and late toxicity results of RTOG 9311:A dose escalation study using 3D conformal radiation therapy in patients with inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 57:S137 (#23), 2003.
41. Werner-Wasik M, Scott C, Movsas B, Langer C, Sarna L, Nicolaou N, Komaki R, Machtay M, Smith C, Axelrod R, Byhardt R. Amifostine as mucosal protectant in patients with locally advanced non-small cell lung cancer (NSCLC) receiving intensive chemotherapy and thoracic radiotherapy (RT): Results of the Radiation Therapy Oncology Group (RTOG) 98-01 study. Int J Radiat Oncol Biol Phys 57:S216 (#152), 2003.
42. Forster KM, Stevens CW, Kitamura K, Chang JY, Cox JD, Guerrero TM, Jeter M, Liao Z, Starkschall G, Komaki R. Changes of tumor motion patterns during a course of radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 57:S234 (#181), 2003.
43. Machtay M, Swann RS, Komaki R, Langer C, Byhardt RW, Sause WT, Curran WJ. Cisplatin dose delivery and survival in concurrent chemoradiation for stage III NSLC: An RTOG secondary analysis. Lung Cancer 42(Suppl 2):S77, 2003.
44. Swisher S, Ajani JA, Komaki R, Putnam J, Walsh G, Liao Z, Yao J, Faust J, Wu T-T, Roth J. CPT-11-taxotere-5-FU regimen for induction and concurretn chemoradiotherapy prior to surgery in patients with resectable esophageal or GEJ carcinoma. Proceedings ASCO 22:272 (#2093), 2003.
45. Itasaka S, Komaki R, Herbst RS, Hunter NR, Onn A, Bucana CD, Milas L, Ang KK, O’reilly MS. Endostatin blocks endothelial repopulation after radiation therapy. Proceedings of the AACR 44 (#115), 2003.
46. Komaki R. Hyperfractionated and accelerated thoracic radiation therapy (HFXA/TRT) incrased survival compared to daily TRT for limited small cell lung cancer (LSCLC) patients treated with concurrent chemotherapy(ChT). Cancer J 9:489 (#18), 2003.
47. Komaki R, Glisson B, Allen P, Fossella F, Liao Z, Stevens C, Blumenschein G, Hong WK, Herbst R, Pisters K. Hyperfractionated and accelerated thoracic radiation therapy (HFXA/TRT) increased survival compared to daily TRT for limited small cell lung cancer (LSCLC) patients treated with concurrent chemotherapy. Lung Cancer 42; Suppl 2:S24, 2003.
48. Langer C, Moughan J, Movsas B, Komaki R, Ettinger D, Owen J, Wilson J. Patterns of care survey (PCS) in locally advaned non-small cell lung cancer (LA-NSCLC) and limited small cell lung cancer (LD-SCLC): How well does current practice follow the literature. Int J Radiat Oncol Biol Phys, 2003.
49. Komaki R, Swann S, Ettinger D, Glisson B, Sandler A, Movsas B, Byhardt R. Phase I dose-escalation study of thoracic irradiation with concurrent chemotherapy for patients with limited small cell lung cancer (LSCLC). Radiation Therapy Oncology Group (RTOG) protocol 9712. Lung Cancer 42(Suppl 2):S104, 2003.
50. Komaki R, Swann S, Ettinger D, Glisson B, Sandler A, Movasa B, Byhardt R. Phase I dose-escalation study of thoracic irradiation with concurrent chemotherapy for patients with limited small cell lung cancer (LSCLC). Radiation Therapy Oncology Group RTOG 9712. Int J Radiat Oncol Biol Phys 57:S139 (#25), 2003.
51. Komaki R, Swann S, Ettinger D, Glisson B, Sandler A, Movsas B, Byhardt R. Phase I dose-escalation study of thoracic irradiation with concurrent chemotherapy for patietns with limited small cell lung cancer (LSCLC). Radiation Therapy Oncology Group (RTOG) protocol 97-12. J Clin Oncol 22:631 (#2539), 2003.
52. Movsas B, Scott C, Langer C, Werner-Wasik M, Nicolaou N, Komaki R, Machtay M, Axelrod R, Byhardt R. Phase III study of amifostine in patients with locally advanced non-small cell lung cancer (NSCLC) receiving chemotehrapy & hyperfractionated radiation (CHEMO/HFXRT): Radiation Therapy Oncology Group (RTOG) 98-01. J Clin Oncol 22:636 (#2559), 2003.
53. Wakelee HA, Stephenson P, Keller SM, Wagner H, Herskovic A, Komaki R, Marks RS, Perry MC, Livingston RB, Johnson DH. Post-operative radiotherapy (PORT) or chemoradiotherapy (CPORT) following resection of stages II and IIIa non-small cell lung cancer (NSCLC) leads to higher than expected risk of death from intercurrent disease. J Clin Oncol 22:633 (#2545), 2003.
54. Movsas B, Moughan J, Komaki R, Chou H, Byhardt R, Langer C, Goldberg M, Graham M, Ettinger D, Johnstone D, Owen J. Radiotherapy patterns of care study in lung carcinoma. Lung Cancer 42(Suppl 2):S30, 2003.
55. Komaki R. Reducing toxicity of combined therapies (Plenary Lecture PL5.2). Proc 17th Asia Pacific Cancer Conference (APCC), Kuta Bali, Indonesia:29, 2003.
56. Graham MV, Paulus R, Ettinger DS, Bradley J, Pilepich M, Machtay M, Komaki R, Atkins J, Curran WJ, Scott C. RTOG 9705, A phase II atrial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIA non-small cell lung cancer (NSCLC) patients – promising long term survival results. Int J Radiat Oncol Biol Phys 57:S140 (#28), 2003.
57. Sasaki R, Komaki R, Macapinlac H, Erasmus J, Allen P, Forster K, Roth J, Putnam JB, Moran C, Cox JD. SUV by FDG-PET predicts outcome of non-small cell lung cancer. Int J Radiat Oncol Biol Phys 57:S166 (#71), 2003.

Book Chapters
1. Onn A, Vaporciyan A, Chang JY, Komaki R, Roth JA, Herbst RS. Cancer of the Lung. In: Cancer Medicine 7, 1179-1224, 2006.
2. Swisher SG, Komaki R, Lynch PM, Agani JA. Esophageal carcinoma. In: Gastrointestinal Cancer, M. D. Anderson Cancer Care Series. Springer-Verlag: New YOrk, 232-245, 2005.
3. Komaki R, Liu H, Murshed H. Lung Cancer. In: Practical Essentials of Intensity Modulated Radiation Therapy. Lippincott Williams & Wilkins, 255-274, 2005.
4. Komaki R Cox JD. Radiation Therapy for Carcinoma of the Lung. In: General Thoracic Surgery. Lippincott Williams & Wilkins, 1377-1388, 2005.
5. Travis E Komaki R. Treatment-related lung damage. In: Lung Cancer Principles and Practice. Lippincott Williams & Wilkins, 545-567, 2005.
6. Swisher SG, Komaki R, Lynch PM, Ajani JA. Esophageal carcinoma. In: Anderson Associates Monograph on Gastroinstestinal Cancer 2004. Springer Verlag, 268-280, 2004.
7. Komaki R, Chang J, Liao Z, Cox JD, Mason KA, Milas L. Radioprotectors and chemoprotectors in the management of lung cancer. In: Medical Radiology-Advances in Radiation Oncology in Lung Cancer. Springer-Verlag, 2004.
8. Komaki R Chang E. Whole-brain Radiation Therapy. In: Intracranial Metastases. Blackwell Publishing, 126-138, 2004.
9. Bradley J, Govindan R, Komaki R. Lung. In: Principles and Practice of Radiation Oncology. Lippincott Williams & Wilkins, 1201-1243, 2003.
10. Komaki R Cox JD. The esophagus. In: Radiation Oncology. Mosby, 429-443, 2003.
11. Komaki R, Travis EL, Cox JD. The lung and thymus. In: Radiation Oncology. Mosby, 399-426, 2003.

Books (edited and written)
1. Cox JD, Chang JY, Komaki R. Ed(s) Cox JD, Chang JY, Komaki R. Image-Guided Radiotherapy of Lung Cancer. Informa, 2007.
2. Fossella FV, Komaki R, Putnam JB. Implementation of multidisciplinary care in the treatment of patients with lung cancer. In: Lung Cancer - Japanese Edition. Springer: Germany, 2003.

Last updated: 9/14/2009